Three LANL Postdocs Invited To 70th Lindau Nobel Laureate Meeting

Los Alamos National Laboratory Post Docs, from left, Chuck Abolt, Andrew Bartlow and Sara de Souza Zanotta Dumit have been invited to the 70th Lindau Nobel Laureate Meeting. Photo Courtesy LANL


Last month, the University of California announced its second class of UC President’s Lindau Nobel Laureate Meetings Fellows, an extraordinary group of 30 young scientists selected from the 10 UC campuses and three national laboratories to attend invitation-only lectures and small seminars with about 40 Nobel laureates from around the world.

Three LANL postdocs have been selected for the 70th Lindau Nobel Laureate Meeting, which takes place this summer.

Chuck Abolt: Computational Earth Science

Los Alamos Director’s Postdoc Fellow Chuck Abolt, a hydrologist and recent R&D 100 Award winner, will join this year’s selective group. Abolt was part of the team that created the award-winning Amanzi-ATS, an open-source software that offers the most complete suite of surface/subsurface physical processes to model complex environmental systems across multiple scales.

Andrew Bartlow: Biosecurity and Public Health

An overarching theme of Andrew Barlow’s work as a scientist is the interconnectedness of living systems and how this translates into interdisciplinary research about such systems. His research ranges from studying the interactions between acorns and seed dispersers (such as birds and small mammals) to how biological communities can be used as signatures of environmental change to the biosurveillance of infectious diseases around the globe.

Sara de Souza Zanotta Dumit: Radiation Protection

Sara de Souza Zanotta Dumit is among the leading theorists working to better understand the biological effects of plutonium intakes and chelation therapy. Her interdisciplinary work requires knowledge of the chemical reactions occurring in different organs, the physics of nuclear decays, the physiology of the human body and drug kinetics. Such models do not currently exist and Dumit’s research will expand our knowledge of how chelation therapy affects the human body.